Strata Skin Sciences, Inc. (NASDAQ:SSKN) shares saw an uptick in trading volume on Tuesday . 732,448 shares were traded during mid-day trading, an increase of 351% from the previous session’s volume of 162,425 shares.The stock last traded at $1.40 and had previously closed at $1.33.
Several research firms have recently weighed in on SSKN. ValuEngine cut shares of Strata Skin Sciences from a “sell” rating to a “strong sell” rating in a report on Monday, October 2nd. HC Wainwright set a $12.00 price target on shares of Strata Skin Sciences and gave the company a “buy” rating in a report on Wednesday, October 18th. Finally, Zacks Investment Research cut shares of Strata Skin Sciences from a “hold” rating to a “sell” rating in a report on Thursday, November 16th.
The company has a market cap of $5.42, a price-to-earnings ratio of -0.23 and a beta of 0.41. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.
Strata Skin Sciences Company Profile
STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.
Receive News & Ratings for Strata Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.